UNSPSC 51144001: Acridorex

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 7SGV5HQH8B. European Medicines Agency schedules Acridorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05249MIG. Acridorex generally arises in the molecular formula C24H24N2.

UNSPSC 51144001 Acridorex, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for public health, emergency response, and community health initiatives. Recent solicitations show state and local agencies buying naloxone and drug deactivation systems, generic pharmaceuticals through multi-state cooperative agreements, and exploring direct-to-manufacturer prescription programs to manage costs and improve fulfillment efficiency. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota MMCAP). Work ranges from tactical commodity purchases of specific naloxone quantities and OTC products to strategic market-intelligence gathering on alternative pharmacy benefit models outside traditional pharmacy benefit managers and group purchasing organizations.

Geographic activity centers on Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing vehicles like MMCAP that serve participating jurisdictions including Oregon. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (due July 26, 2023), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers with proposals due March 26, 2026. The MMCAP solicitation emphasizes pricing competitiveness (75 percent evaluation weight), compliance with cGMP and Drug Supply Chain Security Act requirements, and maintenance of relationships with specific authorized wholesalers, with contract terms of two years and optional extensions. Seminole County's procurement requires quarterly delivery and includes potential FEMA funding with associated federal compliance obligations.